GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzinova AB (OSTO:ALZ) » Definitions » Policy Acquisition Expense

Alzinova AB (OSTO:ALZ) Policy Acquisition Expense


View and export this data going back to 2015. Start your Free Trial

What is Alzinova AB Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Alzinova AB Business Description

Industry
Traded in Other Exchanges
Address
Pepparedsleden 1, Molndal, SWE, SE-431 83
Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is engaged in the development of a specific oligomer-directed vaccine (ALZ-101), and ALZ-201 which is a monoclonal antibody that is specific for the toxic AB oligomers. The products of the company are in the clinical and preclinical stages of development as a therapeutic vaccine for the treatment of Alzheimer's.